Anixa Biosciences, Inc.
ANIX
$2.66
-$0.03-1.12%
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.18% | -7.17% | -30.51% | -37.19% | -40.18% |
| Total Depreciation and Amortization | -30.77% | -25.00% | -72.73% | 0.00% | 18.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -36.82% | -18.63% | 4.92% | 0.91% | 18.82% |
| Change in Net Operating Assets | -72.26% | 299.39% | -385.60% | 73.18% | 58.76% |
| Cash from Operations | -25.77% | 52.92% | -82.91% | -80.42% | -16.15% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,995.35% | 246.21% | 377.96% | 116.14% | 122.05% |
| Cash from Investing | 1,995.35% | 246.21% | 377.96% | 116.14% | 122.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 6,366.67% | 1,123.46% | 2,133.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.77% | -- | -- | -- | -- |
| Cash from Financing | -100.75% | -62.01% | 4,866.67% | 1,007.41% | 75,333.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -362.65% | 102.01% | 109.50% | 99.93% | 103.23% |
